Hanne Damgaard Jensen
Chief Operating Officer at CURASIGHT A/S
Net worth: 5 605 $ as of 2024-05-30
Hanne Damgaard Jensen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CURASIGHT A/S | Chief Operating Officer | 2021-12-31 | - |
| ROS-Therapeutics ApS | Chief Executive Officer | 2017-12-31 | - |
Aimvion A/S
 Aimvion A/S Pharmaceuticals: MajorHealth Technology Aimvion A/S provides services for autoimmune diseases and biotechnology. The private company is based in Copenhagen, Denmark. | Chairman | 2019-12-31 | - |
Career history of Hanne Damgaard Jensen
Former positions of Hanne Damgaard Jensen
| Companies | Position | Start | End |
|---|---|---|---|
Azanta A/S
 Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Chief Executive Officer | 2008-12-31 | 2016-12-31 |
| Corporate Officer/Principal | 2008-12-31 | 2016-12-31 | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Corporate Officer/Principal | 2006-12-31 | 2007-12-31 |
| GENMAB A/S | Corporate Officer/Principal | 1998-12-31 | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | 1994-12-31 | 1998-12-31 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Training of Hanne Damgaard Jensen
| University of Copenhagen | Graduate Degree |
| Scandinavian International Management Institute | Masters Business Admin |
| Copenhagen Business School | Masters Business Admin |
Statistics
International
| Denmark | 11 |
| United States | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Executive Officer | 2 |
| Masters Business Admin | 2 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| GENMAB A/S | Health Technology |
| CURASIGHT A/S | Health Technology |
| Private companies | 4 |
|---|---|
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Health Technology |
Azanta A/S
Azanta A/S Pharmaceuticals: MajorHealth Technology Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark. | Health Technology |
| ROS-Therapeutics ApS | |
Aimvion A/S
Aimvion A/S Pharmaceuticals: MajorHealth Technology Aimvion A/S provides services for autoimmune diseases and biotechnology. The private company is based in Copenhagen, Denmark. | Health Technology |
